Dopamine transporter binding

There are 2 papers on dopamine transporter binding in aging research: none in people yet, 2 reviews.

2 papers study it3 more mention it1 finding

See all 5 papers on dopamine transporter binding

Interventions

1

Acetylcysteine

upin humans1

1 study

Acetylcysteine increases dopamine transporter binding in humans (Parkinson's disease).
“combined intravenous/oral NAC improved dopamine transporter binding”
ReviewParkinson's diseaseintravenous/oral
N-Acetylcysteine in Neurological Disorders: A Systematic Review of Clinical and Translational Evidence Across Seven Disorders
International journal of molecular sciencesMar 27, 2026

More on Acetylcysteine

Latest

2 papers in 12 months

Annals of NeurologyMay 14

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative

ReviewParkinson's disease

International Journal of Molecular SciencesMar 27

N-Acetylcysteine in Neurological Disorders: A Systematic Review of Clinical and Translational Evidence Across Seven Disorders

Systematic reviewAcetylcysteine

TrialsOct 6

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Study protocolEndurance exercise

Nuclear Medicine CommunicationsJul 26

Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography

Cross-sectional study of 133 peopleMechanisms

Parkinsonism & Related DisordersJul 1

Survival in Parkinson's disease in relation to striatal dopamine transporter binding

Cohort study of 162 peopleParkinson's disease